Statement Of Cash Flows [Abstract]

Optomed Oyj - Filing #2177081

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
618,000 EUR
472,000 EUR
Cash flows from (used in) operations before changes in working capital
2 479 EUR
1 579 EUR
Adjustments for decrease (increase) in trade and other receivables
204,000 EUR
1 409 EUR
Adjustments for increase (decrease) in trade and other payables
172,000 EUR
516,000 EUR
Finance costs paid, classified as operating activities
123,000 EUR
64,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
682,000 EUR
0 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.